Respiratory Panel 2

21 Pathogens With Results Reported Within 24 Hours


  • Influenza A
  • Influenza A H1
  • Influenza A H3
  • Influenza A H1-2009
  • Influenza B
  • Respiratory Syncytial Virus
  • Parainfluenza 1
  • Parainfluenza 2
  • Parainfluenza 3
  • Parainfluenza 4
  • Human Metapneumovirus
  • Human Rhinovirus / Enterovirus
  • Adenovirus
  • Coronavirus HKU1
  • Coronavirus NL63
  • Coronavirus OC43
  • Coronavirus 229E


  • Chlamydophila pneumoniae
  • Mycoplasma pneumoniae
  • Bordetella Pertussis
  • Bordetella Parapertussis

BIOFIRE Respiratory Panel 2

Clinical Utility

BioFire Respiratory Panel 2 (RP2) is a qualitative test intended for simultaneous detection and identification of nucleic acids from multiple respiratory viruses and bacteria extracted from nasopharyngeal swabs collected from individuals with clinical signs and symptoms of a respiratory tract infection.

Improve Clinical Outcomes

BioFire RP results have been shown to significantly reduce ICU days and duration of antibiotic use. Optimize patient management with clinically actionable results.

Improve Economic Outcomes

BioFire RP has been shown to reduce overall healthcare costs. Significant savings were demonstrated in an adult ICU population in both patients that tested positive for a respiratory pathogen as well as those that tested negative.

Rapid 24 hour turn around time

98.5% Sensitivity, 99.2% Specificity

Custom reporting with actionable results

Courier service in designated areas

Consultation with an infectious disease expert